Views Navigation

Event Views Navigation

Today

How Patient-Centered Technologies Can Elevate Diabetes Clinical Trials to Align with Current Standards of Care

For years, diabetes clinical trials have been trailing clinical care because of regulatory and logistical challenges with utilizing CGMs in a clinical trial setting. But, because of recent FDA clearance of commercially available devices, these CGM devices have started to be implemented more widely in the clinical trial setting – at least in the United States – but global trials still present challenges.

SCOPE Summit 2025

Rosen Shingle Creek 9939 Universal Blvd, Orlando, FL, United States

Will you be attending SCOPE 2025? Don't miss our session, Unifying Multi-Vendor Wearables/Sensors Data Collection for Clinical Trial Regulatory Compliance on Thursday, February 6, 2025 […]

Decentralized & Hybrid Clinical Trials 2025 Europe

Copthorne Tara Hotel Kensington, London, UK

We’re thrilled to be participating in the Decentralized & Hybrid Clinical Trials World Congress Europe and the Patient Centricity and Collaboration World Congress, which will […]

Scroll to Top

Contact Clinical ink

Request more information, submit questions, set up a demonstration, and more.